Aerpio Pharmaceuticals, Inc. Purchase Agreements

5 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No.3 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, effective as of July 31, 2024, by and between Aadi Bioscience, Inc. and...
Purchase Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
2024
Amendment No.2 to the Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated April 1, 2024, by and between Aadi Bioscience, Inc. and Fresenius...
Purchase Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
2024
Form of Securities Purchase Agreement, dated September 22, 2022, by and among the Company and the Purchasers
Purchase Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated as of January 13, 2022, by and between the Company and Fresenius Kabi, LLC
Purchase Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Asset Purchase Agreement dated August 17, 2021, by and between Aerpio Pharmaceuticals, Inc. and EyePoint Pharmaceuticals, Inc
Purchase Agreements
Aerpio Pharmaceuticals, Inc.
Pharmaceuticals
MA
2021